NEW YORK (GenomeWeb News) – Genetic Technologies today announced an agreement with Three Rivers Provider Network, bringing the total number of covered lives with in-network access to the company's BrevaGen breast cancer test to more than 23 million.
Three Rivers is a supplemental preferred provider organization based in Chula Vista, Calif., and provides healthcare benefits to more than 10 million members at more than 1 million sites across the country.
Today's agreement is the fifth that Melbourne, Australia-based GTG has executed with similar US PPOs, it said. Earlier this week the company reported that its third-quarter revenues narrowed 9 percent year over year. It also announced settlement deals with two companies over lawsuits alleging infringement of a patent held by GTG cover non-coding DNA technology.